Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Medtronic Invests in California Eye Lens Implant Company

By MedCity News – Updated Apr 6, 2017 at 8:34PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

NYSE: MDT

Medtronic plc

Market Cap

$111B

Today's Change

(-1.08%) -$0.90

Current Price

$82.66

Price as of September 23, 2022, 4:00 p.m. ET

The new device aims to mimic a natural lens.

California-based startup PowerVision announced Friday that Medtronic (NYSE: MDT) has become a strategic investor in a $24.7 million funding round that included other investors.

As a result of the investment, Medtronic's Dr. Stephen Oesterle, senior vice president of medicine and technology at Medtronic, will serve as an observer on the board of PowerVision, an ophthalmology company.

PowerVision is developing an "accommodating intraocular lens" that aims to restore a person's ability to adjust focus to see things far and nearby and everything in between. The technology is designed to mimic a normal, functioning lens.

"As the population ages, addressing patient needs in ophthalmology will continue to be extremely important," Oesterle said in a news release. "We're excited to be involved in this novel technology."

Other investors were Venrock, Advanced Technology Ventures, Frazier Healthcare Ventures, and Panorama Capital.

The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Medtronic plc

MDT

$82.66 (-1.08%) $0.90

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Medtronic PLC (MDT) Q4 2021 Earnings Call Transcript

3 Stocks to Buy in a Bear Market

Medtronic Beats on Both Top and Bottom Lines

4 Stocks Making Moves

Will Medtronic Beat These Analyst Estimates?

Motley Fool Returns

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns

339%

S&P 500 Returns

109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Join Stock Advisor

Cumulative Growth of a $10,000 Investment in Stock Advisor

Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.